Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Barkhof

Showing results (61-70 of 396) with videos related to

Pageof 40
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2006
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitusG J Biessels, F-E De Leeuw, J Lindeboom, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2002
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's diseaseS A R B Rombouts, F Barkhof, C S Van Meel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot studyN F Kalkers, F Barkhof, E Bergers, et al.
AJNR. American Journal of Neuroradiology|April 14, 2006
Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matterH Vrenken, S A R B Rombouts, P J W Pouwels, et al.
Human Brain Mapping|March 30, 2000
FMRI of visual encoding: reproducibility of activationW C Machielsen, S A Rombouts, F Barkhof, et al.
Neurology|May 1, 1995
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal agingP Scheltens, F Barkhof, D Leys, et al.
Neurology|March 23, 2005
Treatment with laquinimod reduces development of active MRI lesions in relapsing MSC Polman, F Barkhof, M Sandberg-Wollheim, et al.
Magnetic Resonance Imaging|September 28, 1999
MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studiesM P Sormani, P D Molyneux, F Barkhof, et al.
Neuroimage|August 30, 2001
Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: an event-related fMRI studyS A Rombouts, F Barkhof, M P Witter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 22, 1998
Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groupsN Tubridy, H J Ader, F Barkhof, et al.
Pageof 40

Showing results (61-70 of 396) with videos related to

Sort By:
Pageof 40
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2006
Increased cortical atrophy in patients with Alzheimer's disease and type 2 diabetes mellitusG J Biessels, F-E De Leeuw, J Lindeboom, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 20, 2002
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's diseaseS A R B Rombouts, F Barkhof, C S Van Meel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2002
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot studyN F Kalkers, F Barkhof, E Bergers, et al.
AJNR. American Journal of Neuroradiology|April 14, 2006
Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matterH Vrenken, S A R B Rombouts, P J W Pouwels, et al.
Human Brain Mapping|March 30, 2000
FMRI of visual encoding: reproducibility of activationW C Machielsen, S A Rombouts, F Barkhof, et al.
Neurology|May 1, 1995
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal agingP Scheltens, F Barkhof, D Leys, et al.
Neurology|March 23, 2005
Treatment with laquinimod reduces development of active MRI lesions in relapsing MSC Polman, F Barkhof, M Sandberg-Wollheim, et al.
Magnetic Resonance Imaging|September 28, 1999
MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studiesM P Sormani, P D Molyneux, F Barkhof, et al.
Neuroimage|August 30, 2001
Anterior medial temporal lobe activation during attempted retrieval of encoded visuospatial scenes: an event-related fMRI studyS A Rombouts, F Barkhof, M P Witter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 22, 1998
Exploratory treatment trials in multiple sclerosis using MRI: sample size calculations for relapsing-remitting and secondary progressive subgroups using placebo controlled parallel groupsN Tubridy, H J Ader, F Barkhof, et al.
Pageof 40